382 related articles for article (PubMed ID: 33422003)
1. Trend and treatment outcomes of latent tuberculosis infection among migrant persons in Japan: retrospective analysis of Japan tuberculosis surveillance data.
Kawatsu L; Uchimura K; Ohkado A
BMC Infect Dis; 2021 Jan; 21(1):42. PubMed ID: 33422003
[TBL] [Abstract][Full Text] [Related]
2. Trend and treatment status of latent tuberculosis infection patients in Japan - Analysis of Japan TB Surveillance data.
Kawatsu L; Uchimura K; Ohkado A
PLoS One; 2017; 12(11):e0186588. PubMed ID: 29091917
[TBL] [Abstract][Full Text] [Related]
3. Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study.
Schein YL; Madebo T; Andersen HE; Arnesen TM; Dyrhol-Riise AM; Tveiten H; White RA; Winje BA
BMC Infect Dis; 2018 Nov; 18(1):587. PubMed ID: 30453946
[TBL] [Abstract][Full Text] [Related]
4. A situational analysis of latent tuberculosis infection among incarcerated population in Japan.
Kawatsu L; Uchimura K; Ohkado A
PLoS One; 2018; 13(9):e0203815. PubMed ID: 30192897
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of latent tuberculosis infection in Japan-born and foreign-born children in Japan.
Kasuya S; Imai A; Uchimura K; Ohkado A; Kawatsu L
Western Pac Surveill Response J; 2023; 14(4):1-7. PubMed ID: 38230255
[TBL] [Abstract][Full Text] [Related]
6. Treatment of latent tuberculosis in migrants to Victoria.
Flynn MG; Brown LK
Commun Dis Intell Q Rep; 2015 Dec; 39(4):E578-83. PubMed ID: 26779730
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of nationwide programmatic testing and treatment for latent tuberculosis infection in migrants in England: a retrospective, population-based cohort study.
Berrocal-Almanza LC; Harris RJ; Collin SM; Muzyamba MC; Conroy OD; Mirza A; O'Connell AM; Altass L; Anderson SR; Thomas HL; Campbell C; Zenner D; Phin N; Kon OM; Smith EG; Lalvani A
Lancet Public Health; 2022 Apr; 7(4):e305-e315. PubMed ID: 35338849
[TBL] [Abstract][Full Text] [Related]
8. State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity.
Mirzazadeh A; Kahn JG; Haddad MB; Hill AN; Marks SM; Readhead A; Barry PM; Flood J; Mermin JH; Shete PB
PLoS One; 2021; 16(4):e0249012. PubMed ID: 33793612
[TBL] [Abstract][Full Text] [Related]
9. Estimating the prevalence of latent tuberculosis in a low-incidence setting: Australia.
Dale KD; Trauer JM; Dodd PJ; Houben RMGJ; Denholm JT
Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30361251
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review.
Greenaway C; Pareek M; Abou Chakra CN; Walji M; Makarenko I; Alabdulkarim B; Hogan C; McConnell T; Scarfo B; Christensen R; Tran A; Rowbotham N; van der Werf MJ; Noori T; Pottie K; Matteelli A; Zenner D; Morton RL
Euro Surveill; 2018 Apr; 23(14):. PubMed ID: 29637889
[TBL] [Abstract][Full Text] [Related]
11. Resistance to First-Line Antituberculosis Drugs in Washington State by Region of Birth and Implications for Latent Tuberculosis Treatment Among Foreign-Born Individuals.
Furukawa NW; Haider MZ; Allen SJ; Carlson SL; Lindquist SW
Am J Trop Med Hyg; 2017 Mar; 96(3):543-549. PubMed ID: 27994106
[TBL] [Abstract][Full Text] [Related]
12. Progress Toward Tuberculosis Elimination and Tuberculosis Program Performance - National Tuberculosis Indicators Project, 2016-2022.
Woodruff R; Pratt R; Kolasa M
MMWR Surveill Summ; 2024 Jun; 73(4):1-18. PubMed ID: 38833409
[TBL] [Abstract][Full Text] [Related]
13. Modeling the Cost-Effectiveness of Latent Tuberculosis Screening and Treatment Strategies in Recent Migrants to a Low-Incidence Setting.
Dale KD; Abayawardana MJ; McBryde ES; Trauer JM; Carvalho N
Am J Epidemiol; 2022 Jan; 191(2):255-270. PubMed ID: 34017976
[TBL] [Abstract][Full Text] [Related]
14. National position statement for the management of latent tuberculosis infection.
Stock D;
Commun Dis Intell Q Rep; 2017 Sep; 41(3):E204-E208. PubMed ID: 29720068
[TBL] [Abstract][Full Text] [Related]
15. Risk factors affecting the failure to complete treatment for patients with latent tuberculosis infection in Tokyo, Japan.
Sugishita Y; Goto C; Sakamoto T; Sugawara T; Ohkusa Y
J Infect Chemother; 2020 Nov; 26(11):1129-1133. PubMed ID: 32839113
[TBL] [Abstract][Full Text] [Related]
16. Missed opportunities to prevent tuberculosis in foreign-born persons, Connecticut, 2005-2008.
Guh A; Sosa L; Hadler JL; Lobato MN
Int J Tuberc Lung Dis; 2011 Aug; 15(8):1044-9. PubMed ID: 21740666
[TBL] [Abstract][Full Text] [Related]
17. Policy recommendation: latent tuberculosis infection screening and treatment in children in immigration detention.
Krause V;
Commun Dis Intell Q Rep; 2015 Dec; 39(4):E597-8. PubMed ID: 26779733
[No Abstract] [Full Text] [Related]
18. Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis.
Rustage K; Lobe J; Hayward SE; Kristensen KL; Margineanu I; Stienstra Y; Goletti D; Zenner D; Noori T; Pareek M; Greenaway C; Friedland JS; Nellums LB; Hargreaves S;
Lancet Infect Dis; 2021 Dec; 21(12):1701-1712. PubMed ID: 34363771
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis among asylum seekers in Milan, Italy: epidemiological analysis and evaluation of interventions.
Villa S; Codecasa LR; Faccini M; Pontello MM; Ferrarese M; Castellotti PF; Senatore S; Lamberti A; Mazzola E; Perno CF; Campisi D; Saporiti M; Raviglione MC
Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31413161
[TBL] [Abstract][Full Text] [Related]
20. Analysis of latent tuberculosis infection treatment adherence among refugees and other patient groups referred to the Baltimore City Health Department TB clinic, February 2009-March 2011.
Nuzzo JB; Golub JE; Chaulk P; Shah M
J Immigr Minor Health; 2015 Feb; 17(1):56-65. PubMed ID: 23907316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
